Ability of bone graft substitutes to support the osteoprogenitor cells: An in-vitro study.

AIM To compare seven commercially available bone graft substitutes (BGS) in terms of these properties and without using any additional biological growth factors. METHODS Porcine osteoprogenitor cells were loaded on seven commercially available BGS and allowed to proliferate for one week followed by osteogenic induction. Staining for live/dead cells as well as scanning electron microscopy (SEM) was carried out to determine viability and cellular binding. Further outcome measures included alkaline phosphatase (ALP) assays with normalisation for DNA content to quantify osteogenic potential. Negative and positive control experiments were carried out in parallel to validate the results. RESULTS Live/dead and SEM imaging showed higher viability and attachment with β-tricalcium phosphate (β-TCP) than with other BGS (P < 0.05). The average ALP activity in nmol/mL (normalised value for DNA content in nmol/μg DNA) per sample was 657.58 (132.03) for β-TCP, 36.22 (unable to normalise) for calcium sulphate, 19.93 (11.39) for the Hydroxyapatite/Tricalcium Phosphate composite, 14.79 (18.53) for polygraft, 13.98 (8.15) for the highly porous β-Tricalcium Phosphate, 5.56 (10.0) for polymers, and 3.82 (3.8) for Hydroxyapatite. CONCLUSION Under the above experimental conditions, β-TCP was able to maintain better the viability of osteoprogenitor cells and allow proliferation and differentiation (P < 0.05).

[1]  M. Schieker,et al.  Cell seeding chamber for bone graft substitutes , 2012 .

[2]  G. Calori,et al.  The use of bone-graft substitutes in large bone defects: any specific needs? , 2011, Injury.

[3]  G. Hannink,et al.  Injectable bone-graft substitutes: current products, their characteristics and indications, and new developments. , 2011, Injury.

[4]  H. Fischer,et al.  Scaffolds for bone healing: concepts, materials and evidence. , 2011, Injury.

[5]  P. Giannoudis,et al.  The Effect of Bone Morphogenetic Protein-2, Bone Morphogenetic Protein-7, Parathyroid Hormone, and Platelet-Derived Growth Factor on the Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Osteoporotic Bone , 2010, Journal of orthopaedic trauma.

[6]  P. Giannoudis,et al.  Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today , 2010, International Orthopaedics.

[7]  P. Giannoudis,et al.  NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man , 2010, Journal of cellular and molecular medicine.

[8]  P. Giannoudis,et al.  Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. , 2007, Injury.

[9]  Dong-mei Zhao,et al.  Effect of vascular endothelial growth factor 165 gene transfection on bone defects and its mRNA expression in rabbits , 2007, Chinese medical journal.

[10]  C. Boehm,et al.  Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest. , 2005, The Journal of bone and joint surgery. American volume.

[11]  W. Davros,et al.  Selective Retention of Bone Marrow-Derived Cells to Enhance Spinal Fusion , 2005, Clinical orthopaedics and related research.

[12]  Linda G Griffith,et al.  Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.

[13]  R. Midura,et al.  Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics , 2003, Journal of biomedicine & biotechnology.

[14]  B. Kasemo,et al.  Response of rat osteoblast-like cells to microstructured model surfaces in vitro. , 2003, Biomaterials.

[15]  A. Vaccaro.  The role of the osteoconductive scaffold in synthetic bone graft. , 2002, Orthopedics.

[16]  R. Midura,et al.  Connective tissue progenitors: practical concepts for clinical applications. , 2002, Clinical orthopaedics and related research.

[17]  Arun K Gosain,et al.  A 1-year study of osteoinduction in hydroxyapatite-derived biomaterials in an adult sheep model: part I. , 2002, Plastic and reconstructive surgery.

[18]  R. Bucholz.  Nonallograft osteoconductive bone graft substitutes. , 2002, Clinical orthopaedics and related research.

[19]  Cato T. Laurencin,et al.  Bone-Graft Substitutes: Facts, Fictions, and Applications , 2001, The Journal of bone and joint surgery. American volume.

[20]  K. Burg,et al.  Biomaterial developments for bone tissue engineering. , 2000, Biomaterials.

[21]  G. Muschler,et al.  Bone cells and matrices in orthopedic tissue engineering. , 2000, The Orthopedic clinics of North America.

[22]  N. Scarborough,et al.  Allograft bone. The influence of processing on safety and performance. , 1999, The Orthopedic clinics of North America.

[23]  R. Midura,et al.  Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  M. Chapman,et al.  Treatment of Acute Fractures with a Collagen-Calcium Phosphate Graft Material. A Randomized Clinical Trial*† , 1997, The Journal of bone and joint surgery. American volume.

[25]  H. Takita,et al.  Pore size of porous hydroxyapatite as the cell-substratum controls BMP-induced osteogenesis. , 1997, Journal of biochemistry.

[26]  S. Bruder,et al.  Growth kinetics, self‐renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation , 1997, Journal of cellular biochemistry.

[27]  J. Connolly,et al.  Injectable bone marrow preparations to stimulate osteogenic repair. , 1995, Clinical orthopaedics and related research.

[28]  R. A. Forster,et al.  Alternatives to Autogenous Bone Graft: Efficacy and Indications , 1995, The Journal of the American Academy of Orthopaedic Surgeons.

[29]  E. Bonucci,et al.  Bone sialoprotein (BSP) secretion and osteoblast differentiation: relationship to bromodeoxyuridine incorporation, alkaline phosphatase, and matrix deposition. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  J. Aubin,et al.  Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells , 1991, The Journal of cell biology.

[31]  J F Connolly,et al.  Autologous marrow injection as a substitute for operative grafting of tibial nonunions. , 1991, Clinical orthopaedics and related research.

[32]  J. Healey,et al.  Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. , 1990, Clinical orthopaedics and related research.

[33]  C. Maniatopoulos,et al.  Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats , 1988, Cell and Tissue Research.

[34]  R. Holmes,et al.  Bone Regeneration Within a Coralline Hydroxyapatite Implant , 1979, Plastic and reconstructive surgery.

[35]  T. Albert,et al.  Physical and monetary costs associated with autogenous bone graft harvesting. , 2003, American journal of orthopedics.

[36]  C T Laurencin,et al.  Proliferation, morphology, and protein expression by osteoblasts cultured on poly(anhydride-co-imides). , 1999, Journal of biomedical materials research.

[37]  K. Sell,et al.  Studies on the antigenicity of bone. II. Donor-specific anti-HLA antibodies in human recipients of freeze-dried allografts. , 1984, The Journal of bone and joint surgery. American volume.